Muhammad Nisar Khan1, Haleema Khan2, Muhammad Shahzad3,4, Muhammad Ibrahim2, Muhammad Arif2, Zeeshan Kibria5, Usman Waheed6, Noore Saba1, Inayat Shah3, Yasar Mehmood Yousafzai2,7. 1. Regional Blood Centre Peshawar, Pakistan. 2. Institute of Pathology & Diagnostic Medicine, Khyber Medical University Peshawar, Pakistan. 3. Institute of Basic Medical Sciences, Khyber Medical University Peshawar, Pakistan. 4. School of Biological Sciences University of Reading Reading, UK. 5. Office of Research Innovation & Commercialization, Khyber Medical University Peshawar, Pakistan. 6. Islamabad Blood Transfusion Authority, Ministry of National Health Services Islamabad, Pakistan. 7. Institute of Infection, Immunity and Inflammation, University of Glasgow Glasgow, UK.
Abstract
BACKGROUND AND OBJECTIVES: To determine the seroprevalence of SARS-CoV-2 antibodies and the associated risk factors among healthy blood donors from Peshawar Pakistan, during the second and third waves of the COVID-19 pandemic. METHODS: The study was conducted on 4047 healthy (with no history or symptoms of COVID-19) blood donors attending regional blood center Peshawar between Nov 2020 and June 2021. Demographic data was collected and donors were screened for the presence of anti-SARS-CoV-2 antibodies using electrochemiluminescence immunoassay (ECLIA). RESULTS: The mean age of the participants was 27.27±7.13 and the majority (99%) were males. Overall, 59% (2391/4047) of the blood donors were reactive for SARS-CoV-2 antibodies. An increasing trend in seropositivity was observed from 45.5% to 64.8% corresponding to the second and third wave of the pandemic in Pakistan. Logistic regression analysis revealed significantly higher odds of seropositivity among male donors compared to females. Similarly, in multivariable analysis, the odds ratio for seropositivity among blood types AB, A, and B were, 1.6, 1.4, and 1.3 (CI 95%) times higher compared to blood group O (P-value ≤0.0001). CONCLUSIONS: Seropositivity of SARS-CoV-2 antibodies among blood donors gradually increased during the second and third wave of the pandemic in Pakistan indicating a widespread prevalence of Covid-19 in the general population. Susceptibility to SARS-CoV-2 varies with ABO blood types, with blood group O associated with low risk of infection. AJBR
BACKGROUND AND OBJECTIVES: To determine the seroprevalence of SARS-CoV-2 antibodies and the associated risk factors among healthy blood donors from Peshawar Pakistan, during the second and third waves of the COVID-19 pandemic. METHODS: The study was conducted on 4047 healthy (with no history or symptoms of COVID-19) blood donors attending regional blood center Peshawar between Nov 2020 and June 2021. Demographic data was collected and donors were screened for the presence of anti-SARS-CoV-2 antibodies using electrochemiluminescence immunoassay (ECLIA). RESULTS: The mean age of the participants was 27.27±7.13 and the majority (99%) were males. Overall, 59% (2391/4047) of the blood donors were reactive for SARS-CoV-2 antibodies. An increasing trend in seropositivity was observed from 45.5% to 64.8% corresponding to the second and third wave of the pandemic in Pakistan. Logistic regression analysis revealed significantly higher odds of seropositivity among male donors compared to females. Similarly, in multivariable analysis, the odds ratio for seropositivity among blood types AB, A, and B were, 1.6, 1.4, and 1.3 (CI 95%) times higher compared to blood group O (P-value ≤0.0001). CONCLUSIONS: Seropositivity of SARS-CoV-2 antibodies among blood donors gradually increased during the second and third wave of the pandemic in Pakistan indicating a widespread prevalence of Covid-19 in the general population. Susceptibility to SARS-CoV-2 varies with ABO blood types, with blood group O associated with low risk of infection. AJBR
Authors: Zia UlHaq; Muhammad Shahzad; Maria Ishaq Khattak; Sheraz Fazid; Naeem Ullah; Akhtar Shireen; Naeem Ulhaq; Asif Izhar; Umer Farooq; Nizam Muhammad Darwesh; Muhammad Asim; MianGul Ali Gohar; Amber Ashraf; Saad Ishaq Khattak; Saadia Ashraf; Shahzad Akbar; Muhammad Fawad; Muhammad Ismail Khan; Amir Amanullah; Muhammad Siddiq; Azizul Hasan Amir Journal: J Ayub Med Coll Abbottabad Date: 2020 Oct-Dec
Authors: Matthew P Cheng; Cedric P Yansouni; Nicole E Basta; Michaël Desjardins; Sanjat Kanjilal; Katryn Paquette; Chelsea Caya; Makeda Semret; Caroline Quach; Michael Libman; Laura Mazzola; Jilian A Sacks; Sabine Dittrich; Jesse Papenburg Journal: Ann Intern Med Date: 2020-06-04 Impact factor: 25.391
Authors: Michael A Johansson; Talia M Quandelacy; Sarah Kada; Pragati Venkata Prasad; Molly Steele; John T Brooks; Rachel B Slayton; Matthew Biggerstaff; Jay C Butler Journal: JAMA Netw Open Date: 2021-01-04
Authors: Adam J Kucharski; Timothy W Russell; Charlie Diamond; Yang Liu; John Edmunds; Sebastian Funk; Rosalind M Eggo Journal: Lancet Infect Dis Date: 2020-03-11 Impact factor: 25.071